Low-grade fibromyxoid sarcoma
Low-grade fibromyxoid sarcoma (LGFMS) is a rare type of soft tissue sarcoma that typically presents as a slow-growing, painless mass. It was first described by Evans HL in 1987. Despite its benign appearance, LGFMS can metastasize many years after initial diagnosis, often to the lungs.
Clinical presentation[edit | edit source]
Patients with LGFMS often present with a slow-growing, painless mass. The tumor can occur anywhere in the body, but it is most commonly found in the deep soft tissues of the extremities, particularly the thigh. Other common sites include the trunk and the neck. LGFMS can occur at any age, but it is most common in young adults.
Pathology[edit | edit source]
On gross examination, LGFMS is typically a well-circumscribed, lobulated mass with a grey-white cut surface. Microscopically, the tumor is composed of bland spindle cells arranged in a whorled pattern, with alternating areas of fibrous and myxoid stroma. The tumor cells have small, uniform nuclei and scant cytoplasm. Mitotic figures are rare. Immunohistochemically, the tumor cells are usually positive for vimentin and negative for S100, desmin, and smooth muscle actin.
Diagnosis[edit | edit source]
The diagnosis of LGFMS is based on the characteristic histologic and immunohistochemical features. However, the diagnosis can be challenging due to the tumor's bland appearance and slow growth. Molecular testing can be helpful in confirming the diagnosis. The most common genetic alteration in LGFMS is a fusion of the FUS and CREB3L2 genes.
Treatment[edit | edit source]
The mainstay of treatment for LGFMS is surgical resection with clear margins. Radiation therapy may be used in cases where complete surgical resection is not possible. Chemotherapy is generally not effective for LGFMS.
Prognosis[edit | edit source]
The prognosis for patients with LGFMS is generally good, with a 5-year survival rate of over 90%. However, the tumor can metastasize many years after initial diagnosis, often to the lungs. Regular follow-up is therefore important for patients with LGFMS.
See also[edit | edit source]
Low-grade fibromyxoid sarcoma Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD